Head-to-head
Oak Longevity vs Ro: GLP-1 Prices Compared
Released: Last reviewed:
No like-for-like tirzepatide verdict: Oak Longevity does not offer tirzepatide; Ro could not be re-read (last record 2026-08-11).
Only prices read on the providers’ own pages on October 15, 2026 produce a verdict here; older records are shown with their dates and are not compared. Confirm the total at checkout.
Tirzepatide: Oak Longevity vs Ro
| Oak Longevity | Ro | |
|---|---|---|
| All-in monthly at maintenance | Not offered | $598/mo |
| Cheapest 12-month route, per month | Not offered | $598/mo |
| 12-month cost | Not offered | $7,176 |
| Membership / program fee | Not offered | $149/mo |
| Dose pricing | Not offered | Brand list pricing by product and dose |
| Status | Not offered | Reported · 2026-08-11 · not re-read |
The arithmetic
No like-for-like tirzepatide verdict: Oak Longevity does not offer tirzepatide; Ro could not be re-read (last record 2026-08-11).
Semaglutide: Oak Longevity vs Ro
| Oak Longevity | Ro | |
|---|---|---|
| All-in monthly at maintenance | $133/mo | $498/mo |
| Cheapest 12-month route, per month | $133/mo | $498/mo |
| 12-month cost | $1,596 | $5,976 |
| Membership / program fee | None | $149/mo |
| Dose pricing | Dose-flat (stated) | Brand list pricing by product and dose |
| Status | Provider-stated · 2026-08-08 · not re-read | Reported · 2026-08-11 · not re-read |
The arithmetic
No like-for-like semaglutide verdict: Oak Longevity could not be re-read (last record 2026-08-08); Ro could not be re-read (last record 2026-08-11).
Terms side by side
Oak Longevity
- BillingMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner 503A pharmacy (not publicly itemized)
Ro
- BillingMembership month-to-month ($39 first month; ~$74/mo prepaid annual)
- CancellationCancel anytime
- PharmacyBrand fulfillment via NovoCare / LillyDirect pathways
Questions people ask
Why is there no price verdict for Oak Longevity vs Ro?
No like-for-like tirzepatide verdict: Oak Longevity does not offer tirzepatide; Ro could not be re-read (last record 2026-08-11). No like-for-like semaglutide verdict: Oak Longevity could not be re-read (last record 2026-08-08); Ro could not be re-read (last record 2026-08-11). We only compare figures read on the providers’ own pages on the same date.
Are compounded GLP-1s from either program FDA-approved?
No compounded tirzepatide or semaglutide is FDA-approved, and neither is a generic version of Zepbound, Mounjaro, Wegovy or Ozempic. Brand products sold by LillyDirect and NovoCare are FDA-approved. Ask which pharmacy fills your prescription and check its state license.
What will checkout show that this page does not?
Taxes, state availability, current promotions and any change made after our read date. Screenshot the order summary before you pay; that screen, not a comparison page, shows what you are agreeing to.
Records: Oak Longevity · Ro · price database · downloads. Official sites: Oak Longevity ↗ · Ro ↗.